1-(4-甲基苯基)-1-环己腈 | 1206-13-9

• 物质功能分类: 有机原料 - 烃类化合物及其衍生物 - 芳香烃
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-(4-甲基苯基)-1-环己腈
• 中文别名: 1-对甲苯基环己腈
• 英文名称: 1-(4-methylphenyl)cyclohexanecarbonitrile
• 英文别名: 1-(4-methyl-phenyl)-1-cyclohexyl-carbonitrile；1-cyano-1-(4-methylphenyl)cyclohexane；1-(4-methylphenyl)cyclohexane-1-carbonitrile
• CAS: 1206-13-9
• 化学式: C₁₄H₁₇N
• mdl: MFCD00066917
• 分子量: 199.296
• InChiKey: JFUXEEYLCATFIB-UHFFFAOYSA-N

物化性质

• 沸点：
  326.83°C (rough estimate)
• 密度：
  1

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  23.8
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xn
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R20/21/22,R36/37/38

SDS

Name:	1-(4-Methylphenyl)-1-cyclohexanecarbonitrile 97% Material Safety Data Sheet
Synonym:	1-(4-Methylphenyl)cyclohexanecarbonitril
CAS:	1206-13-9

Section 1 - Chemical Product MSDS Name:1-(4-Methylphenyl)-1-cyclohexanecarbonitrile 97% Material Safety Data Sheet
Synonym:1-(4-Methylphenyl)cyclohexanecarbonitril

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
1206-13-9	1-(4-Methylphenyl)-1-cyclohexanecarbon	97	214-888-4

Hazard Symbols: XN
Risk Phrases: 20/21/22

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 1206-13-9: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Clear liquid
Color: clear, colorless
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Not available.
Specific Gravity/Density: 1.0060g/cm3
Molecular Formula: C14H17N
Molecular Weight: 199.29

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 1206-13-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(4-Methylphenyl)-1-cyclohexanecarbonitrile - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 1206-13-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 1206-13-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1206-13-9 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-(4-甲基苯基)-1-环己腈 在 ferric(III) bromide 、 二异丁基氢化铝 作用下， 以 甲苯 为溶剂， 反应 20.0h， 生成 环己基-(4-甲基苯基)甲酮
  参考文献：
  名称：

  Fe催化的α-芳基醛的区域发散[1,2]-位移

  摘要：

  已经开发了通过 [1,2] 转移将醛催化转化为酮的方法。这种骨架重排显示出广泛的底物范围和化学选择性特征，同时表现出优异的 [1,2]-芳基或 [1,2]-烷基转移选择性，可通过电子效应轻松切换。

  DOI：

  10.1021/ja4068707
• 作为产物：
  描述：

  对甲基苯乙腈 、 alkaline earth salt of/the/ methylsulfuric acid 在 sodium hexamethyldisilazane 作用下， 生成 1-(4-甲基苯基)-1-环己腈
  参考文献：
  名称：

  Fe催化的α-芳基醛的区域发散[1,2]-位移

  摘要：

  已经开发了通过 [1,2] 转移将醛催化转化为酮的方法。这种骨架重排显示出广泛的底物范围和化学选择性特征，同时表现出优异的 [1,2]-芳基或 [1,2]-烷基转移选择性，可通过电子效应轻松切换。

  DOI：

  10.1021/ja4068707

文献信息

• REDUCED COENZYME Q10 DERIVATIVE AND METHOD FOR PRODUCTION THEREOF
  申请人：KANEKA CORPORATION

  公开号：US20150307440A1

  公开（公告）日：2015-10-29

  A reduced coenzyme Q 10 derivative represented by formula (1), wherein R 1 and R 2 are each independently H or an alkoxycarbonyl group represented by formula (2), and at least one of them is an alkoxycarbonyl group represented by the formula (2); in the formula (2), R 3 is an optionally substituted linear, branched, or cyclic alkyl group having 1 to 20 carbon atoms, an optionally substituted aryl group having 6 to 20 carbon atoms, or an optionally substituted heteroaryl group having 4 to 20 carbon atoms, and when R 3 is a group substituted with polyethylene glycol, the molecular weight of the polyethylene glycol is not more than 300.

  公式（1）所代表的一种还原辅酶Q10衍生物，其中R1和R2分别独立地为H或由公式（2）表示的烷氧羰基团，且它们中至少有一个是由公式（2）表示的烷氧羰基团；在公式（2）中，R3是一个可选择地取代的线性、支链或环烷基基团，其含有1至20个碳原子，一个可选择地取代的含有6至20个碳原子的芳基基团，或一个可选择地取代的含有4至20个碳原子的杂芳基团，当R3是一个取代了聚乙二醇的基团时，聚乙二醇的分子量不超过300。
• Brønsted Acid-Promoted Hydrocyanation of Arylalkenes
  作者：Arata Yanagisawa、Tetsuya Nezu、Shin-ichiro Mohri

  DOI：10.1021/ol902244e

  日期：2009.11.19

  Nonactivated arylalkenes are effectively converted to tertiary benzylic nitriles in the presence of triflic acid and trimethylsilyl cyanide. The hydrocyanation reactions result in good to excellent yield when electron-donating groups are substituted on the benzene ring. The reaction conditions are mild and relatively safe, notably without need for handling hazardous hydrogen cyanide gas, providing

  在三氟甲磺酸和三甲基甲硅烷基氰化物的存在下，未活化的芳基烯烃可以有效地转化为叔苄基腈。当给电子基团被取代在苯环上时，氢氰化反应导致良好或极好的收率。反应条件温和且相对安全，特别是无需处理危险的氰化氢气体，从而可轻松轻松地获得叔苄基腈。该反应被用于制备PDE4抑制剂（3）以及一系列类似物。
• N-substituted heterocyclic derivatives useful in the treatment of
  申请人：Elf Sanofi, A French Corp.

  公开号：US05274104A1

  公开（公告）日：1993-12-28

  The present invention relates to N-substituted heterocyclic derivatives of formula: ##STR1## processes for their preparation, and pharmaceutical compositions which contain them. The compounds according to the invention are non-peptide compounds which oppose the action of angiotensin II. The compounds according to the invention are thus useful in the treatment of cardiovascular disorders such as hypertension and heart failure.

  本发明涉及公式为N-取代杂环衍生物的化合物，其制备方法以及含有它们的药物组合物。根据本发明的化合物是非肽类化合物，可以对抗血管紧张素II的作用。因此，根据本发明的化合物在治疗高血压和心力衰竭等心血管疾病方面具有用途。
• STABILIZATION METHOD OF REDUCED COENZYME Q10
  申请人：UEDA Takahiro

  公开号：US20070258966A1

  公开（公告）日：2007-11-08

  The present invention provides a method for stabilizing reduced coenzyme Q 10 , which is useful as a food, nutritional product, nutritional supplement, animal drug, drink, feed, cosmetic, pharmaceutical product, therapeutic drug, prophylactic drug and the like. The present invention also provides a method of producing a reduced coenzyme Q 10 -containing composition which includes the co-presence of reduced coenzyme Q 10 and reduced coenzyme Q 9 and/or reduced coenzyme Q 11 .

  本发明提供了一种稳定还原型辅酶Q10的方法，可用作食品、营养产品、营养补充剂、动物药品、饮料、饲料、化妆品、药用产品、治疗药物、预防药物等。本发明还提供了一种生产含有还原型辅酶Q10的组合物的方法，其中包括还原型辅酶Q10和还原型辅酶Q9和/或还原型辅酶Q11的共存。
• [EN] METHOD OF PURIFYING REDUCED COENZYME Q<br/>[FR] METHODE DE PURIFICATION DE LA COENZYME Q REDUITE
  申请人：KANEKA CORP

  公开号：WO2004063131A1

  公开（公告）日：2004-07-29

  The object of the present invention is to provide a method of purifying reduced coenzyme Q10 to produce a high-quality product which is useful as an ingredient in foods, functional nutritive foods, specific health foods, nutritional supplements, nutrients, animal drugs, drinks, feeds, cosmetics, medicines, remedies, preventive drugs, etc., by a efficient manner suitable for an industrial scale production. The present invention relates to a method of purifying reduced coenzyme Q10 which comprises washing crystals and/or oil of reduced coenzyme Q10 with a water-soluble organic solvent or a mixed solvent composed of a water-soluble organic solvent and water to thereby remove water-soluble impurities, especially a reducing agent or impurities derived from a reducing agent, from the crystals and/or oil of reduced coenzyme Q10. The present invention makes it possible to conveniently and efficiently purify reduced coenzyme Q1o in a manner excellent in operationality, and to obtain a high-quality reduced coenzyme Q10.

  本发明的目的是提供一种将还原辅酶Q10纯化以生产高质量产品的方法，该产品可用作食品、功能性营养食品、特定健康食品、营养补充剂、营养品、动物药品、饮料、饲料、化妆品、药品、药物疗法、预防药物等的成分，通过适合工业规模生产的高效方法。本发明涉及一种纯化还原辅酶Q10的方法，包括用水溶性有机溶剂或由水溶性有机溶剂和水组成的混合溶剂清洗还原辅酶Q10的晶体和/或油，以去除晶体和/或油中的水溶性杂质，特别是来自还原剂或还原剂衍生物的杂质。本发明使得可以方便高效地纯化还原辅酶Q10，具有出色的操作性，并获得高质量的还原辅酶Q10。

表征谱图